GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV
GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV is a hedge fund based in Boston, Massachusetts. According to its most recent Form D, filed Dec 11, 2025, the fund has sold $179,600,966 of interests to 3 investors since its first sale in Mar 2022. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Arron Day; David Bohan; John Fitzpatrick.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $179,600,966Cumulative sales reported on Form D
- Investors
- 3
- First sale
- Mar 7, 2022
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- Arron Day; David Bohan; John Fitzpatrick
- Latest Form D
- Dec 11, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV
What is the minimum investment for GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV?
GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV's latest Form D, filed Dec 11, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV?
GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV raised?
GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV reports $179,600,966 sold from 3 investors on its Form D filed Dec 11, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV based?
GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV is based in Boston, Massachusetts.
When did GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV launch?
GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV reports its first sale in Mar 2022.
Size compared with every hedge fund
Raised more than 56% of the 474 hedge funds based in Massachusetts, and more than 67% of all 10,307 that report sales.
Other funds with the same team
- GMO Equity Dislocation Fund, L.P.$2.7B
- GMO Equity Dislocation Fund (Offshore), L.P.$1.1B
- GMO Amplified Equity Dislocation Solution Fund, L.P.$1.0B
- Manatee Cove Partners EMD Fund, L.P.$500M
- GMO Emerging Country Debt UCITS Fund, a sub-fund of GMO Investments ICAV$87.5M
- GMO World Market Neutral Fund, L.P.$85.0M
- GMO Climate Change Select Transition Investment Fund, a sub-fund of GMO Investments ICAV$7.3M